Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors

Open Heart. 2021 Apr;8(1):e001655. doi: 10.1136/openhrt-2021-001655.
No abstract available

Keywords: COVID-19; cardiomyopathy; electronic health records; hypertrophic.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • COVID-19*
  • Humans
  • Ivermectin* / pharmacology
  • Receptors, Glycine
  • SARS-CoV-2

Substances

  • Anti-Inflammatory Agents
  • Receptors, Glycine
  • Ivermectin